These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 22573165

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.
    Skerry CM, Mahon BP.
    Clin Vaccine Immunol; 2011 Feb; 18(2):187-93. PubMed ID: 21147936
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection.
    Locht C, Papin JF, Lecher S, Debrie AS, Thalen M, Solovay K, Rubin K, Mielcarek N.
    J Infect Dis; 2017 Jul 01; 216(1):117-124. PubMed ID: 28535276
    [Abstract] [Full Text] [Related]

  • 8. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M, Odanaka K, Otsuka N, Kamachi K, Watanabe M.
    Microbiol Immunol; 2016 Sep 01; 60(9):599-608. PubMed ID: 27515393
    [Abstract] [Full Text] [Related]

  • 9. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
    Feunou PF, Kammoun H, Debrie AS, Mielcarek N, Locht C.
    Vaccine; 2010 Oct 08; 28(43):7047-53. PubMed ID: 20708998
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS, Coutte L, Raze D, Mooi F, Alexander F, Gorringe A, Mielcarek N, Locht C.
    Vaccine; 2018 Mar 07; 36(11):1345-1352. PubMed ID: 29433898
    [Abstract] [Full Text] [Related]

  • 12. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.
    Mielcarek N, Debrie AS, Mahieux S, Locht C.
    Clin Vaccine Immunol; 2010 Mar 07; 17(3):317-24. PubMed ID: 20107007
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate.
    Lim A, Ng JK, Locht C, Alonso S.
    Microbes Infect; 2014 Jan 07; 16(1):51-60. PubMed ID: 24140230
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.
    van den Berg BM, David S, Beekhuizen H, Mooi FR, van Furth R.
    Vaccine; 2000 Dec 08; 19(9-10):1118-28. PubMed ID: 11137247
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Construction of the genetically attenuated bacteria Bordetella pertussis devoid of dermonecrotic toxin activity and producing modified nontoxic pertussis toxin form].
    Siniashina LN, Siniashina LS, Semin EG, Amelina IP, Karataev GI.
    Mol Gen Mikrobiol Virusol; 2010 Dec 08; (3):31-6. PubMed ID: 20886687
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.